﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>American Journal of Medical Case Reports</journalTitle>
    <eissn>2374-216X</eissn>
    <publicationDate>2022-09-05</publicationDate>
    <volume>10</volume>
    <issue>9</issue>
    <startPage>214</startPage>
    <endPage>217</endPage>
    <doi>10.12691/ajmcr-10-9-1</doi>
    <publisherRecordId>AJMCR20221091</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Kratom Associated Withdrawal Symptoms and Naltrexone: A Case Report</title>
    <authors>
      <author>
        <name>Reece Vesperman</name>
        <email>peacevesman@gmail.com</email>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Shalinee Wayland</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Shemar Crawford</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Corinne Jackson</name>
        <affiliationId>2</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Pensacola Regional Campus, Florida State University College of Medicine, Pensacola, United States of America</affiliationName>
      <affiliationName affiliationId="2">Department of Emergency Medicine, Baptist Hospital, Pensacola, United States of America</affiliationName>
    </affiliationsList>
    <abstract language="eng">Kratom (Mitragyna speciosa Korth), an indigenous herb of Southeast Asia, is popularly used to treat withdrawal symptoms associated with opiate addiction and a myriad of ailments including chronic pain, anxiety and hypertension. Its use has significantly increased in western countries because of its widespread advertisement on the internet as a safe, nonaddictive alternative treatment of pain and opioid dependent disorders. This report describes the first emergency case of toxic encephalopathy, rhabdomyolysis, and liver injury in relation to kratom withdrawal syndrome induced by naltrexone in a 49-year old male. The symptoms were resolved with a regimen of dexmedetomidine, lorazepam, oral lactulose, and a bicarbonate drip. Outpatient treatment with lorazepam and tramadol was recommended for further withdrawal symptoms.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/10/9/1/ajmcr-10-9-1.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>kratom</keyword>
      <keyword>withdrawal</keyword>
      <keyword>opioid</keyword>
      <keyword>toxicity</keyword>
      <keyword>naltrexone</keyword>
    </keywords>
  </record>
</records>